atai Advances Phase 2 Trial of VLS-01 for Depression
The Phase 2 Elumina trial, a significant clinical study by atai Life Sciences, is underway, targeting the treatment of treatment-resistant... Lire la suite
March 15, 2025
Recently Published Articles
atai Life Sciences Completes Phase 2b TRD Trial Enrollment
Atai Life Sciences (NASDAQ: ATAI), a leader in the biopharmaceutical sector, has successfully completed patient enrollment for the core stage... Lire la suite
March 10, 2025
atai Life Sciences at TD Cowen Health Care Event
atai Life Sciences (NASDAQ: ATAI), a trailblazer in the biopharmaceutical sector, is set to participate in the TD Cowen 45th... Lire la suite
March 1, 2025
Positive Phase 2a Results for atai’s BPL-003 in AUD
In a recent groundbreaking study by atai Life Sciences and Beckley Psytech, the innovative treatment BPL-003 has shown promising results... Lire la suite
February 3, 2025
atai Life Sciences Elevates Leadership for Mental Health
atai Life Sciences Announces Leadership Team Enhancements New York and Berlin – atai Life Sciences (NASDAQ: ATAI), a pioneer in... Lire la suite
January 11, 2025
Most Popular Articles
